Cargando…

Safe and appropriate use of diclofenac in chronic kidney disease: An Indian perspective

Pain is most common symptom associated with progressive disorder, chronic kidney disease (CKD), and is usually undertreated during the early stages of CKD. So, present review was conducted to evaluate the challenges for the management of pain in CKD patients and addresses the scope for considering D...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sheth, Sharad, Thakur, Sneha, Thorat, Anup, Gupta, Pankaj
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8415660/ https://www.ncbi.nlm.nih.gov/pubmed/34568119 http://dx.doi.org/10.4103/jfmpc.jfmpc_2358_20

Ejemplares similares

Pharmacokinetic profile of an intradeltoid diclofenac injection in obese Indian volunteers
por: Shep, Dhaneshwar, et al.
Publicado: (2010)

A Single Oral Dose of Diclofenac Causes Transition of Experimental Subclinical Acute Kidney Injury to Chronic Kidney Disease
por: Störmer, Johanna, et al.
Publicado: (2022)

Acute Kidney Injury and Hyperkalemia With Precarious Electrocardiographic Changes Caused by Concurrent Use of Telmisartan and Diclofenac
por: Gaba, Saurabh, et al.
Publicado: (2020)

Efficacy and Tolerability of Erenumab for Prevention of Episodic Migraine in India
por: Chowdhury, Debashish, et al.
Publicado: (2022)

Niacin in patients with chronic kidney disease: Is it effective and safe?
por: Park, Cheol Whee
Publicado: (2013)

Is percutaneous nephrolithotomy safe in chronic kidney disease patients!!!
por: Adiga, Pramod, et al.
Publicado: (2022)

Diclofenac-induced Sweet's syndrome
por: Gupta, Sunil Kumar, et al.
Publicado: (2015)

Evaluation of Homocysteine and Gamma-Glutamyl Transferase Concentrations As Markers of Chronic Kidney Disease: An Indian Perspective
por: R, Shyamkrishnan, et al.
Publicado: (2022)

Appropriate use of inhaled corticosteroids in COPD: the candidates for safe withdrawal
por: Yawn, Barbara P, et al.
Publicado: (2016)

The appropriate troponin T level associated with coronary occlusions in chronic kidney disease patients
por: Sittichanbuncha, Yuwares, et al.
Publicado: (2015)

Simulation based learning: Indian perspective
por: Kundra, Pankaj, et al.
Publicado: (2014)

Chronic cough: An Indian perspective
por: Faruqi, Shoaib, et al.
Publicado: (2015)

DICLOFENAC: NEW DATA ON CHRONIC TOXICITY AND BIOCONCENTRATION IN FISH
por: Memmert, Ulrich, et al.
Publicado: (2013)

Evolving locally appropriate models of care for Indian sickle cell disease
por: Serjeant, Graham R.
Publicado: (2016)

Wilson disease – Challenge for safe anesthesia!
por: Kaur, Arminder, et al.
Publicado: (2019)

Safe use of radiopharmaceuticals in patients with chronic kidney disease: a systematic review
por: Schreuder, Nanno, et al.
Publicado: (2021)

Baclofen-induced neurotoxicity in chronic kidney disease: Is there a safe dose?
por: Varma, Prem P., et al.
Publicado: (2022)

Discharge of late preterm newborn: appropriated, controlled…namely safe
por: Coscia, A, et al.
Publicado: (2014)

A Review of Topical Diclofenac Use in Musculoskeletal Disease
por: Nair, Bindu, et al.
Publicado: (2010)

The Indian Chronic Kidney Disease (ICKD) study: baseline characteristics
por: Kumar, Vivek, et al.
Publicado: (2021)

Chronic Kidney Disease: Role of Diet for a Reduction in the Severity of the Disease
por: Naber, Tania, et al.
Publicado: (2021)

Cathepsin S as an early biomarker for cardiovascular disease in chronic kidney disease patients
por: Sonkar, Satyendra Kumar, et al.
Publicado: (2022)

Diclofenac topical solution compared with oral diclofenac: a pooled safety analysis
por: Roth, Sanford H, et al.
Publicado: (2011)

Tolerability of diclofenac sodium 1% gel with concomitant medications known to interact with diclofenac
por: Peniston, John H, et al.
Publicado: (2013)

Diclofenac in the treatment of pain in patients with rheumatic diseases
por: Kołodziejska, Justyna, et al.
Publicado: (2018)

Active educational intervention as a tool to improve safe and appropriate use of antibiotics
por: Shehadeh, Mayadah B., et al.
Publicado: (2016)

Prevalence of chronic kidney disease in two major Indian cities and projections for associated cardiovascular disease
por: Anand, Shuchi, et al.
Publicado: (2015)

Identification of novel mutations in glucocerebrosidase (GBA) gene in Indian patients with gaucher disease (GD)
por: Ankleshwaria, Chitra, et al.
Publicado: (2014)

Parent's Perspectives on the End-of-life Care of their Child with Cancer: Indian Perspective
por: Latha, Sneha Magatha, et al.
Publicado: (2016)

Enhancing safe motherhood: Effect of novel partograph on labor outcomes and its utility: An Indian perspective
por: Sharma, Shivani, et al.
Publicado: (2022)

Efficacy and Safety of Oral Diclofenac Sustained release Versus Transdermal Diclofenac Patch in Chronic Musculoskeletal Pain: A Randomized, Open Label Trial
por: Shinde, Viraj Ashok, et al.
Publicado: (2017)

Noninvasive assessment of bone health in Indian patients with chronic kidney disease
por: Jabbar, Z., et al.
Publicado: (2013)

Pulmonary Hypertension in Various Stages of Chronic Kidney Disease in Indian Patients
por: Mehta, Kalpana S., et al.
Publicado: (2019)

Importance of the formulation in the skin delivery of topical diclofenac: not all topical diclofenac formulations are the same
por: Pradal, Julie, et al.
Publicado: (2019)

AYURVEDA, AN APPROPRIATE STRATEGY FOR SOCIAL HEALTH: An overview of the Indian Panorama
por: Bijoy, C. R.
Publicado: (1981)

Expanding the spectrum of HEXA mutations in Indian patients with Tay–Sachs disease
por: Sheth, Jayesh, et al.
Publicado: (2014)

A Review of Chronic Musculoskeletal Pain: Central and Peripheral Effects of Diclofenac
por: Atzeni, Fabiola, et al.
Publicado: (2018)

Prevalence of chronic kidney disease and risk factors for its progression: A cross-sectional comparison of Indians living in Indian versus U.S. cities
por: Anand, Shuchi, et al.
Publicado: (2017)

Pain management in chronic pancreatitis incorporating safe opioid practices: Challenge accepted
por: Shah, Ishani, et al.
Publicado: (2021)

Thyroid dysfunction and dyslipidemia in chronic kidney disease patients
por: Khatiwada, Saroj, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_4dhvi9rus859nou5gon43qnsrv